Allosteric modulators of human A2B adenosine receptor

被引:21
作者
Trincavelli, Maria Letizia [1 ]
Giacomelli, Chiara [1 ]
Daniele, Simona [1 ]
Taliani, Sabrina [1 ]
Cosimelli, Barbara [2 ]
Laneri, Sonia [2 ]
Severi, Elda [2 ]
Barresi, Elisabetta [1 ]
Pugliesi, Isabella [1 ]
Greco, Giovanni [2 ]
Novellino, Ettore [2 ]
Da Settimo, Federico [1 ]
Martini, Claudia [1 ]
机构
[1] Univ Pisa, Dipartimento Farm, I-56126 Pisa, Italy
[2] Univ Naples Federico II, Dipartimento Farm, I-80131 Naples, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2014年 / 1840卷 / 03期
关键词
1-Benzyl-3-ketoindole derivatives; A(2B) adenosine receptor; Positive allosteric modulators; Negative allosteric modulators; GPCR allosteric modulators; Ligand-receptor interaction; INTERNATIONAL UNION; HIGH-AFFINITY; A2B RECEPTOR; PROTEIN; ANTAGONISTS; CLASSIFICATION; PHARMACOLOGY; NOMENCLATURE; DERIVATIVES; EXPRESSION;
D O I
10.1016/j.bbagen.2013.12.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Among adenosine receptors (ARs) the Am subtype exhibits low affinity for the endogenous agonist compared with the A(1), A(2A), and A(3) subtypes and is therefore activated when concentrations of adenosine increase to a large extent following tissue damages (e.g. ischemia, inflammation). For this reason, A(2B) AR represents an important pharmacological target. Methods: We evaluated seven 1-benzyl-3-ketoindole derivatives (7-9) for their ability to act as positive or negative allosteric modulators of human A(2B) AR through binding and functional assays using CHO cells expressing human A1, A(2A), A(2B), and A(3) ARs. Results: The investigated compounds behaved as specific positive or negative allosteric modulators of human A(2B) AR depending on small differences in their structures. The positive allosteric Modulators 7a,b and 8a increased agonist efficacy without any effect on agonist potency. The negative allosteric modulators 8b,c and 9a,b reduced agonist potency and efficacy. Conclusions: A number of 1-benzyl-3-ketoindole derivatives were pharmacologically characterized as selective positive (7a,b) or negative (8c, 9a,b) allosteric modulators of human A(2B) AR. General significance: The 1-benzyl-3-ketoindole derivatives 7-9 acting as positive or negative allosteric modulators of human A(2B) AR represent new pharmacological tools useful for the development of therapeutic agents to treat pathological conditions related to an altered functionality of A(2B) AR. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:1194 / 1203
页数:10
相关论文
共 53 条
[1]   Neuronal guidance molecule netrin-1 attenuates inflammatory cell trafficking during acute experimental colitis [J].
Aherne, Carol M. ;
Collins, Colm B. ;
Masterson, Joanne C. ;
Tizzano, Marco ;
Boyle, Theresa A. ;
Westrich, Joseph A. ;
Parnes, Jason A. ;
Furuta, Glenn T. ;
Rivera-Nieves, Jesus ;
Eltzschig, Holger K. .
GUT, 2012, 61 (05) :695-705
[2]   A2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression [J].
Allaman, I ;
Lengacher, S ;
Magistretti, PJ ;
Pellerin, L .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (03) :C696-C704
[3]   Recent improvements in the development of A2B adenosine receptor agonists [J].
Baraldi, Pier Giovanni ;
Tabrizi, Mojgan Aghazadeh ;
Fruttarolo, Francesca ;
Romagnoli, Romeo ;
Preti, Delia .
PURINERGIC SIGNALLING, 2009, 5 (01) :3-19
[4]   Why are A2B receptors low-affinity adenosine receptors?: Mutation of Asn273 to Tyr increases affinity of human A2B receptor for 2-(1-hexynyl) adenosine [J].
Beukers, MW ;
Den Dulk, H ;
Van Tilburg, EW ;
Brouwer, J ;
Ijzerman, AP .
MOLECULAR PHARMACOLOGY, 2000, 58 (06) :1349-1356
[5]  
Castelhano A.L., 2003, PCT Int. Appl., Patent No. [WO 2003053361, 2003053361]
[6]   G protein-coupled receptor allosterism and complexing [J].
Christopoulos, A ;
Kenakin, T .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :323-374
[7]   Differences in the allosteric modulation by phenytoin of the binding properties of the σ1 ligands [3H](+)-pentazocine and [3H]NE-100 [J].
Cobos, EJ ;
Lucena, G ;
Baeyens, JM ;
Del Pozo, E .
SYNAPSE, 2006, 59 (03) :152-161
[8]   A1 adenosine receptor antagonists, 3-aryl [1,2,4]triazino[4,3-a]benzimidazol-4-(10H)-ones (ATBIs) and N-alkyl and N-acyl-(7-substituted-2-phenylimidazo[1,2-a][1,3,5]triazin-4-yl)amines (ITAs):: Different recognition of bovine and human binding sites [J].
Da Settimo, F ;
Primofiore, G ;
Taliani, S ;
La Motta, C ;
Novellino, E ;
Greco, G ;
Lavecchia, A ;
Cosimelli, B ;
Iadanza, M ;
Klotz, KN ;
Tuscano, D ;
Trincavelli, ML ;
Martini, C .
DRUG DEVELOPMENT RESEARCH, 2004, 63 (01) :1-7
[9]   Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist [J].
Eastwood, Paul ;
Esteve, Cristina ;
Gonzalez, Jacob ;
Fonquerna, Silvia ;
Aiguade, Josep ;
Carranco, Ines ;
Domenech, Teresa ;
Aparici, Monica ;
Miralpeix, Montserrat ;
Alberti, Joan ;
Cordoba, Monica ;
Fernandez, Raquel ;
Pont, Merce ;
Godessart, Nuria ;
Prats, Neus ;
Isabel Loza, Maria ;
Isabel Cadavid, Maria ;
Nueda, Arsenio ;
Vidal, Bernat .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (03) :213-218
[10]   A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice [J].
Eckle, Tobias ;
Grenz, Almut ;
Laucher, Stefanie ;
Eltzschig, Holger K. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (10) :3301-3315